Five Innovations to Take RNA Vaccines to the Next Level

July 10, 2023 / by Ellen Shafer

Venkata Indurthi, PhD, CSO of Aldevron, bylined this article in Labiotech, Five Innovations to Take RNA Vaccines to the Next Level.

"To further maximize the potential of RNA vaccines, emphasis needs to be put on streamlining production and improving vaccine stability. RNA vaccines are still costly to make; therefore, the production process needs to be further streamlined to reduce production times and make RNA vaccines more cost-effective."

• Read the entire article here